| Authors: |
Aguirre LE; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Section of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.; Harvard T.H. Chan School of Public Health, Boston, MA., Bewersdorf JP; Section of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT., Liu Y; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., Shallis RM; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Boussi L; Memorial Sloan Kettering Cancer Center, New York, NY., Zucenka A; Department of Hematology and Oncology, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania., Garciaz S; Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, Aix-Marseille Université, INSERM, Centre National de la Recherche Scientifique, Marseille, France., Bystrom RP; Division of Hematologic Malignancies and Cellular Therapy, Duke Blood Cancer Center, Durham, NC., DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Luskin MR; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Garcia JS; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Winer ES; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Ling K; Section of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT., Chen EC; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Wadleigh M; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Berton G; Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, Aix-Marseille Université, INSERM, Centre National de la Recherche Scientifique, Marseille, France., Stein EM; Memorial Sloan Kettering Cancer Center, New York, NY., Goldberg AD; Memorial Sloan Kettering Cancer Center, New York, NY., Mendez L; Section of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT., Zeidan AM; Section of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT., Sallman DA; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Shimony S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Stahl M; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Section of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT. |
